Research Use Only. Not for human or veterinary use. Not medical advice.

RU-SLK · Neuropeptide Research

RU-SLK vial (catalog image)

RU-SLK

Neuropeptide Research

Catalog code Research material Lyophilized format Variable presentations
Presentation

Vial: reconstitution solution sold separately. Mist Sprayer: includes 5 mL saline solution.

Pricing
Sign in
Researcher pricing for approved accounts
In stock
As listed on the public catalog, Nov 17, 2026
Add to cart
0 25 50 75
76 of 100

Popularity

High

Public interest index

Trending down-23% vs prior 30 days

Research: Literature Activity 6/10 · Moderate (PubMed volume)

Data as of Nov 17, 2026 · Sources: Wikipedia pageviews, Reddit, X public mentions.

Measures online attention only. It is not a measure of quality, purity, efficacy, or safety.

Publications per year

Unique PubMed records grouped by publication year — a volume index, not a quality rating.

PubMed counts

Last updated Nov 17, 2026. 138 unique records for (selank OR "Thr-Lys-Pro-Arg-Pro-Gly-Pro"). 2026 is a partial year. Cards on this page concern tuftsin-analogue identity and laboratory gene-expression work. Anxiolytic-outcome, withdrawal, and clinical-treatment papers are omitted on purpose and are not restated here. Source on PubMed

Key specifications

Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.

Catalog title
RU-SLK | Neuropeptide Research
Research focus
Neuropeptide Research
Also described as
Selank · tuftsin analogue · Thr-Lys-Pro-Arg-Pro-Gly-Pro
Format
Lyophilized research peptide
Catalog status
In stock (public listing)
Presentations
Vial (reconstitution solution sold separately) and Mist Sprayer (includes 5 mL saline solution)Catalog sizes, not a protocol
Molecular formula
C33H57N11O9PubChem CID 11765600
Molecular weight
751.9PubChem average for CID 11765600
Receptor context
Described in the literature as a synthetic tuftsin analoguePublished identity literature; research context only
Sequence
Not reproduced hereSee primary literature / PubChem
Researcher access
Sign-in required to view pricing
PubMed records
138 uniqueQuery above, Nov 17, 2026

Catalog notes & use limitations

Research-catalog framing only. This section does not describe effects in people or study outcomes.

Catalog notes

Listed under Neuropeptide Research

RU-SLK appears in the PEPTIDEA™ neuropeptide research collection with RC-SMX and RC-ADX.

Tuftsin-analogue identity; no outcome cards

Cards below concern analogue identity and gene-expression models. Papers whose main point is anxiety, withdrawal, or clinical treatment are omitted on purpose.

Vial and Mist Sprayer presentations

The public listing is a variable product whose attribute is Options (Vial or Mist Sprayer). The catalog SKU RC-412-10 is consistent with a 10 mg presentation mass, but the picker on this page follows the catalog Options attribute. Presentations are not a protocol.

Use limitations

Research use only

Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.

No outcome or dosing information

This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.

Confirm details from primary sources

Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.

Specifications

Laboratory-catalog and public-chemistry details. Items without a cited source are marked.

Catalog titleRU-SLK | Neuropeptide Research
CategoryNeuropeptide Research
Associated namesSelank; synthetic tuftsin analogue; Thr-Lys-Pro-Arg-Pro-Gly-Pro
FormatLyophilized research peptide
Public catalog statusIn stock (as of Nov 17, 2026)
Catalog presentationsVial (reconstitution solution sold separately) and Mist Sprayer (includes 5 mL saline solution) — sizes of the research material, not a use protocol
Molecular formulaC33H57N11O9 (PubChem CID 11765600, retrieved Nov 17, 2026)
Molecular weight751.9 (PubChem average for CID 11765600)
InChIKeyJTDTXGMXNXBGBZ-YVHUGQOKSA-N (PubChem)
Receptor contextPublished papers describe Selank as a synthetic heptapeptide analogue of tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro). That is an identity description, not an anxiolytic or other use claim.
SequenceNot reproduced on this page. See primary literature and the PubChem record.
PricingVisible after researcher sign-in
CID 11765600 is cited for formula and mass.

Research literature

These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.

Review — tuftsin and analogues

Siebert et al.

Current Medicinal Chemistry · 2017
Tuftsin, its properties, and published analogues

This review surveys tuftsin and published analogues. It is included because Selank is described in the literature as a tuftsin analogue, not because the review is a study of this catalog vial.

Applied or clinical wording in the review is not restated on this page.

Experimental, gene-expression study

Volkova et al.

Frontiers in Pharmacology · 2016
Selank and expression of genes involved in GABAergic neurotransmission

This paper examined Selank and the expression of some genes involved in GABAergic neurotransmission. It is included as laboratory gene-expression literature, not as an anxiolytic-outcome study.

Gene-expression measurements and any behavioral inferences in the paper are not reproduced here.

Experimental, cell-line gene expression

Filatova et al.

Frontiers in Pharmacology · 2017
GABA, Selank, and olanzapine in a gene-expression study of IMR-32 cells

This paper examined GABA, Selank, and olanzapine in a gene-expression study of IMR-32 cells. It is a cell-line laboratory study. Olanzapine appears only as a co-studied comparator in that paper and is not a component of this catalog material.

Gene-expression findings in the paper are not restated on this page.

Identity note

Catalog identity note

Research-profile note · 2026
Selank described as a synthetic tuftsin analogue

Published papers describe Selank as a synthetic tuftsin analogue with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. That identity is recorded here so the listing can be read against the named-compound literature. This note is not a paper card and not a use claim.

No clinical or behavioral findings are restated here.

Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query (selank OR "Thr-Lys-Pro-Arg-Pro-Gly-Pro"). Source on PubMed

Storage & handling

General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.

  • Handle as a lyophilized research material intended for laboratory use only.
  • Store according to the conditions printed on the label and in any compound document provided to approved researchers.
  • Protect closed vials from moisture and unnecessary temperature swings.
  • If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
  • This material is not for human or veterinary use and is not medical advice.
No dosing, administration, or protocol instructions are included on this page.

Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.